I

Intellia Therapeutics

Cambridge, United States Founded 2014 NASDAQ: NTLA
Gene Therapy Delivery Nanomedicine Cell Therapy Nano Nano-Bio Lipid Nanoparticles mRNA Delivery

About

Gene editing company using lipid nanoparticle delivery for in vivo CRISPR therapeutics

Company Details

Type
commercial
Employees
500-1000
Funding
Public

Key Products

  • NTLA-2001
  • CRISPR/Cas9 Platform
Visit Website

Related Companies

N

Nanosys

Milpitas, United States

N

Nanosphere (Luminex)

Northbrook, United States

N

Nanocomp Technologies

Merrimack, United States

N

NanoString Technologies

Seattle, United States